<DOC>
	<DOCNO>NCT00918138</DOCNO>
	<brief_summary>The purpose study compare effect Saxagliptin add-on Metformin 24-hour mean weight glucose ( MWG ) effect uptitrating Metformin subject T2DM inadequately control metformin alone .</brief_summary>
	<brief_title>Study To Evaluate 24 Hour Blood Sugar Control ( 24-hour Mean Weighted Glucose ) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes 1878 year age Taking stable dose metformin immediate release ( IR ) XR ≥850 mg ≤1500 mg monotherapy least 8 week prior screen Glycosylated hemoglobin A1C ( A1C ) 7.511.5 % screen Fasting Cpeptide : ≥1.0 ng/mL FPG≥126 mg/dl obtain Day 7 visit Body mass index ( BMI ) : ≤ 40kg/m² A1C ≥ 7.0 % ≤ 11.0 % obtain Day 7 visit randomization Women childbearing potential unable unwilling use acceptable birth control Women pregnant breastfeeding Significant cardiovascular history Active liver disease Renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>